Transparency Market Research Report Added "mTOR Inhibitors Market" to its database.
Albany, NY -- (SBWIRE) -- 02/18/2016 -- A new research report by Transparency Market Research (TMR) presents a comprehensive overview as well as an unbiased analysis of the global market for mTOR inhibitors. The study, titled "mTOR Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020," is available for sale on TMR's website.
According to the market study, the increasing prevalence of cancer across the world is the key factor behind the remarkable growth of the worldwide market for mTOR inhibitors. Mammalian target of rapamycin (mTOR) is a type of protein kinase that controls cell growth and angiogenesis, and hyper activeness of which causes cancer in human beings. mTOR inhibitors block the activity of mTOR, helping in the treatment of various types of cancer.
The infrastructural improvement in the global medical and healthcare industry is another factor that is fuelling the global market for mTOR significantly. However, the technical complexity and high cost associated with the mTOR diagnosis procedure is expected to hamper the growth of this market over the forecast period.
Get Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2594
The global market for mTOR inhibitors is spread across North America, Asia Pacific, Europe, and the Rest of the World, says the report. In 2013, North America and Europe led the worldwide market on account of the presence of major market participants in these regions. The high prevalence of cancer in North America and Europe is also fueling these regional markets for mTOR inhibitors.
Further, the report says that Asia Pacific is emerging as the most attractive market for mTOR inhibitors, owing to ample untapped opportunities it offers. In addition to this, the rapid infrastructural development in the medical and healthcare industry in this region is projected to boost the Asia Pacific market for mTOR inhibitors during the forecast period.
On the other hand, the mTOR inhibitors market in Rest of the World is likely to witness sluggish growth, owing to the prevalence of poor economic conditions and the lack of proper healthcare infrastructure in Africa, says the report.
The report also maps the competitive landscape of the global mTOR inhibitors market by evaluating the company profiles of major market players. LC Laboratories, Exelixis, Biotool, Novartis, BioLegend, Enzymlogic, Fluofarma, Enzo Biochem, UniProt, and Cell Signaling Technology Inc. are the key players operating in the global mTOR inhibitors market, states the research study.
The main objective of this market study is to provide a clear picture of the global mTOR market to participants, stakeholders, and consultants in order to help them in making crucial strategies for the further expansion of their businesses.
Mr. Sudip S
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453